Pfizer to seek approval for third vaccine dose; shots still protect

Pfizer’s Dr. Mikael Dolsten has said that early data from the company's booster study suggests people’s antibody levels jump five- to 10-fold after a third dose

Pfizer to seek approval for third vaccine dose; shots still protect
Linkup
Pfizer’s Dr. Mikael Dolsten has said that early data from the company's booster study suggests people’s antibody levels jump five- to 10-fold after a third dose